insights_auto
Why is RCEL down 4.53%?
Dive Deeperchevron_right
RCEL:NASDAQ
AVITA Medical Inc
$12.65
arrow_downward
-4.53%(-0.60) 1D
Oct 6, 10:03:17 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RCEL...
Open
$13.38
High
$13.50
Low
$12.63
Mkt. cap
375.58M
Avg. vol.
304.90K
Volume
53.67K
52-wk high
$13.50
52-wk low
$3.22
EPS
-$1.44
Beta
1.99
Shares outstanding
30.93M
No. of employees
226
Open
$13.38
High
$13.50
Low
$12.63
Mkt. cap
375.58M
Avg. vol.
304.90K
Volume
53.67K
52-wk high
$13.50
52-wk low
$3.22
EPS
-$1.44
Beta
1.99
Shares outstanding
30.93M
No. of employees
226
News stories
From web sources and news partners
AD HOC NEWS
·
1 hour ago
AVITA Medical reaches 52-week high and AVITA Medical stock trades 2.62 percent higher
AD HOC NEWS
·
3 hours ago
Avita Medical stock gained 4.17 percent near its yearly high
Kalkine Media
·
15 hours ago
AVITA Medical Director Dr. Michael Tarnoff Converts 8,750 RSUs into Common Shares
Profile
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersValencia, California, United States
SectorBiotechnology
Websiteavitamedical.com